首页> 外国专利> TREATMENT AND PREVENTION OF CARDIAC DISORDERS USING SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRI)

TREATMENT AND PREVENTION OF CARDIAC DISORDERS USING SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRI)

机译:选择性5-羟色胺再摄取抑制剂(SSRI)的治疗和预防心脏疾病

摘要

The present invention relates to a method for the treatment and / or prevention of cardiac disorders, such as those associated with thrombotic pathogenesis, such as myocardial infarction, in humans or animals by administering a single tonotonin reuptake inhibitor (SSRI), such as paroxetine, fluoxetine, fluoxetine, to a human or animal in need thereof. or an effective non-toxic amount of a pharmaceutically acceptable salt thereof. The invention further relates to the use of an SSRI or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment and / or prevention of cardiac disorders, such as those associated with the pathogenesis of atrombosis, such as myocardial infarction. The invention also relates to the pharmaceutical compositions thus prepared. SHE
机译:[0001]本发明涉及通过施用单一的Toononin再摄取抑制剂(SSRI)(例如帕罗西汀)来治疗和/或预防人或动物中的心脏疾病(例如与血栓形成机制相关的疾病,例如心肌梗塞)的方法,氟西汀,氟西汀,针对需要其的人或动物。或其有效无毒量的可药用盐。本发明进一步涉及SSRI或其药学上可接受的盐在制备用于治疗和/或预防心脏疾病(例如与萎缩症的发病机理相关的疾病,例如心肌梗塞的疾病)的药物中的用途。本发明还涉及由此制备的药物组合物。她

著录项

  • 公开/公告号HU0002643A2

    专利类型

  • 公开/公告日2001-10-28

    原文格式PDF

  • 申请/专利权人 SMITHKLINE BEECHAM PLC.;

    申请/专利号HU20000002643

  • 发明设计人 JENNER PAUL NORMAN;

    申请日1998-07-14

  • 分类号A61K31/445;

  • 国家 HU

  • 入库时间 2022-08-22 01:25:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号